IND
Xtrackers Nifty 500 India ETFstockNASDAQETF
InactiveDec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)393
IND Reddit Mentions by subreddit
Loading…
IND Mentions × sentiment
Loading…
IND Specific Mentions latest comments & posts
I've been digging through ACTU since its Nov 18 ENA presentation. Oral elraglusib's active formulation showed 50% tumor growth inhibition with once daily dosing & 77% with twice daily dosing in an aggressive B16F10 melanoma mouse model. They also reported more cytotoxic T cells & natural killer cells in the tumors, with fewer immunosuppressive myeloid cells. Interesting biology. Still mice, not patients.
What caught my attention was the exposure response. More drug exposure came with greater antitumor activity. They're aiming for a Phase 1/2 oral study in Q1 2027 starting with refractory metastatic melanoma. The FDA already cleared the IND but human exposure, tolerability & actual efficacy are still unanswered.
Theres human data for IV elraglusib in pancreatic cancer too. A randomized Phase 2 trial reported median overall survival of 10.1 months with elraglusib plus gemcitabine/nab-paclitaxel vs 7.2 months with chemo alone. Thats not a trivial result. But its a different cancer & a different formulation. Cant just carry those numbers over to oral melanoma.
Now the ugly part. The October offering & November underwriter exercise added 35.63M common shares with warrants covering another 17.82M shares. Total common shares outstanding reached 60.38M as of Nov 13. The latest 10Q still raises substantial doubt about the company continuing as a going concern. Nasdaq compliance is another headache. They raised cash but the longer term funding problem isnt gone.
I can like what the research is showing without liking what happens to shareholders when the company needs more money.
So what actually changes the valuation here? Human oral exposure & tolerability data that backs up what they saw in mice? Or a clearer regulatory & funding path for the pancreatic program?
Because another good looking mouse study doesnt solve the capital problem.
sentiment -0.770
Through IND money
sentiment 0.000
Clearmind announced publication of a Hong Kong patent application for its PTSD compound family today.
We went through the underlying Yissum license, patent record and SEC filings to see where the program actually stands.
The patent footprint is expanding, but the public development plan does not reach a first human study until roughly 2030–2032, and Clearmind has not disclosed a lead candidate, IND or human trial for this program.
sentiment -0.029
I am a newbie and want to start investing in US ETF from India. Primarily I see IND money, Vested and Ticker tape.
With Ticker tape it's asking for a minimum investment of 10,000-50,000 INR even in the Pro plan.
IND money feels so overwhelming to use. And Vested is costly maybe!
What do you guys use? And I've heard about the GIFT city investment platform too. Can anyone please help me with it?
sentiment 0.775
Hey everyone!
I thought I'd share my interview experiences with various HFTs, hedge funds, and trading firms. I've appeared for quite a few processes, both internationally and IND, across C++, SWE, Quant Trader, Quant Researcher, Python, and AI/ML roles.
Some processes went surprisingly well, some were genuinely challenging, and a few ended for reasons that were completely out of my control.
I'm a 2026 CSE graduate, and most of these applications were for international positions. I figured sharing my experiences might help others preparing for similar roles.
I'll try to cover the interview rounds, the kind of questions asked, and where things eventually ended.
# International HFTs and Hedge Funds
# 1. Akuna Capital – C++ Developer
This was one of my first serious HFT interview processes.
* Cleared OA 1.
* Cleared OA 2 (debugging round).
* Got invited to three virtual interview rounds.
The interviews were quite technical. Most of the discussions revolved around C++, programming concepts, internal workings of the language, and debugging.
They went pretty deep into C++ rather than just asking standard DSA questions.
I felt the overall process went reasonably well, but I wasn't particularly confident about one of the debugging rounds. Looking back, I think that might have been the reason I didn't make it through.
# 2. Mako Trading – Quant Trader
The initial assessments consisted of two rounds, mainly focusing on:
* Puzzles and aptitude
* Probability
* Mathematical reasoning
* General problem-solving
I cleared both assessments and received an invitation for the first interview.
The first round was primarily a problem-solving round with puzzles.
The second round was quite different. We discussed my projects in depth, followed by probability questions and some market-related research questions.
It was an interesting process because the focus was more on mathematical thinking and problem-solving than traditional software engineering. (No response after this, recruiter said hiring freeze for this cycle)
# 3. Maven Securities – Quant Trader
The assessment process consisted of:
* Coding assessment
* Numerical assessment
* Standardised assessment through Arctic Shores
I managed to clear all the assessments and received an interview invitation.
The first interview covered my projects, probability, brainteasers, and market-making concepts.
Unfortunately, I couldn't clear this round.
One of the reasons, in hindsight, was that I didn't have enough practical knowledge of market making and some of the concepts and technologies they expected me to understand.
It was a good learning experience, though. It made me realise that solving probability questions alone isn't enough for a Quant Trader role.
# 4. IMC Trading – Software Engineer (Chicago)
The process started with a coding assessment, followed by a recruiter call and the first technical interview.
I cleared the first interview and received confirmation from the recruiter.
However, around that time, there were changes in US H-1B visa policies, and the recruiter coordinator informed me that IMC had paused hiring for international candidates for that location.
They suggested applying to their European positions instead.
I applied for Amsterdam, received another OA, and cleared it as well. This was confirmed by them.
Unfortunately, I never received a further update after that. There wasn't any formal rejection either, so I'm still not entirely sure what happened.
# 5. Optiver – Software Engineer (Amsterdam)
I cleared the online assessment and got invited to the first technical interview.
I was able to solve the coding problem, but I eventually got rejected.
The interesting part was that solving the problem wasn't enough. The interviewer wanted much more clarity around my approach, reasoning, and the internal details of how things worked.
It was a good reminder that in these interviews, communication and explaining your thought process are just as important as arriving at the correct solution.
# 6. Headlands Technologies – Research Developer (New York)
This was probably one of the most interesting interview experiences I've had.
The online assessment was quite challenging. They gave very little time (around 10 minutes) for the coding questions, and the assessment had multiple parts.
Despite the time constraint, I managed to clear it and received an invitation for the first interview.
**Round 1:**
The entire discussion was centred around one of my research projects.
We went into a lot of detail about the implementation, research methodology, and optimization techniques I had used.
**Round 2:**
This round covered:
* Probability and puzzles
* Detailed project discussion
* Optimization-related proofs
* C++ concepts
What made this process particularly interesting was the depth of the project discussion. They had actually gone through my GitHub repositories and asked questions based on the implementation.
It was probably the first time I experienced an interview where the interviewer examined my projects at such a granular level.
Unfortunately, I received a rejection email after the second round.
Still, I genuinely appreciated the experience because it showed me how seriously research-oriented firms evaluate your actual work.
# HFTs / Trading Firms in IND
Now coming to the firms. These processes were quite different from the international ones in terms of interview structure and expectations.
# 1. Graviton Research Capital – Software Engineer
A recruiter reached out to me regarding an SWE opportunity, and we scheduled the interviews.
**Round 1 – DSA**
This was probably one of the most unexpected interview experiences I've had.
The interviewer joined the call, opened an ICPC World Finals 2025 problem, and asked me to solve it within an hour.
My first reaction was honestly something like, "Oh no, this is an ICPC World Finals problem!"
I knew these problems could be extremely difficult, but I had an hour, so I decided to give it my best shot.
I started working through the problem, developed the approach, implemented it, and eventually managed to solve it.
The solution passed all the test cases in one go, which felt really satisfying.
**Round 2 – DSA + Puzzles**
The second round again involved DSA, along with some puzzles.
After that, I didn't receive an update for around two weeks. I followed up with the recruiter, who mentioned that they were still evaluating other candidates.
One important thing here was that the position required 2+ years of experience, whereas I'm a 2026 graduate.
Eventually, they filled the position with someone who had the required experience.
However, the recruiter mentioned that she was impressed with my performance and would reach out again when suitable opportunities opened up.
Of course, not getting selected was disappointing, but considering the experience requirement, I was still happy with how the interviews went.
# 2. NK Securities – Python Developer
The process started with an online assessment, followed by two interview rounds.
I cleared the first interview.
The second round focused on Python and system design.
I didn't have much practical knowledge of designing systems in Python at that point, so I couldn't clear this round.
It highlighted an area I needed to work on beyond just Python programming and DSA.
# 3. AlphaGrep – Quant Researcher
This was my first interview process specifically for a Quant Research role.
The process involved an OA followed by two interview rounds.
Honestly, the bar was quite high.
There were some challenging mathematical and probability questions, along with puzzles that I couldn't solve.
I wouldn't say the questions were impossible, but they were definitely outside my comfort zone at the time.
Overall, this wasn't my best interview performance, but it gave me a better understanding of what Quant Research interviews actually look like.
# 4. Kivi Capital – AI/ML
A recruiter reached out regarding an AI/ML opportunity.
There were supposed to be five rounds in total.
At that time, I was already interviewing with several companies, including Amazon, Graviton, Powerplay, Theom, and Kivi Capital. Managing all these processes simultaneously was quite hectic, but I still decided to give it a shot.
The rounds covered:
* **Round 1:** DSA and AI/ML fundamentals.
* **Round 2:** More DSA and some puzzles.
* **Round 3:** Extremely detailed discussion around my ML project.
The third round went quite deep into my project and its implementation.
After that round, I didn't receive any further updates.
# 5. APT Portfolio – Python Developer
A recruiter reached out to me for a Python Developer position.
I appeared for the first interview, but unfortunately, the company went into a hiring freeze.
So the process stopped there.
It's frustrating when something like this happens, especially when you're not even getting evaluated further, but that's part of the hiring market.
# 6. Greenland Investment Management – Infrastructure Role
I'm currently interviewing with Greenland Investment Management for an infrastructure-focused role.
The process is still ongoing, so I'll share more about this experience once it concludes.
# Some observations from these experiences
After going through so many different interview processes, I've noticed a few things:
1. **HFT interviews are not just about DSA**
2. **Your projects actually matter**
3. **Clearing the OA doesn't mean much by itself**
4. **Communication matters a lot**
5. **Role-specific knowledge is important**
Not going to lie, there have been quite a few disappointments along the way.
You clear an OA, prepare for interviews, go through multiple rounds, sometimes feel that you've performed well, and then eventually receive a rejection or simply don't hear back.
It can get frustrating.
But at the same time, I'm glad I got the opportunity to interview with these firms. Every process exposed me to something new, whether it was low-level C++ internals, probability, market making, optimization, research discussions, or difficult competitive programming problems.
I'm still learning and improving, and hopefully, the current process works out.
**I'd also love to hear from people working at HFTs or hedge funds:**
* For someone starting as a 2026 graduate, what would you recommend focusing on to eventually get into top-tier firms?
* How important is practical market-making knowledge for Quant Trader roles compared to probability and mathematical problem-solving?
* For Research Developer / Infrastructure roles, how much C++ internals, OS, networking, and systems knowledge is generally expected?
* And for those who have interviewed at firms like Jane Street, Citadel, HRT, Jump Trading, Optiver, and IMC, how different are their interview expectations?
Happy to discuss any of these interview experiences in more detail if it helps someone preparing for similar opportunities!
sentiment 0.999
First DD on a company in my own workfield.
I've been looking into Metagenomi ($MGX) recently, and I think this small-cap biotech deserves some attention.
There are two things that make MGX particularly interesting right now in my opinion:
**1. FDA clearance for MGX-001**
On November 10, Metagenomi announced that the FDA had cleared its IND application for MGX-001, its experimental gene-editing treatment for Hemophilia A.
This is a major milestone. It means the company can move forward with its Phase 1/2 INTEGR8 clinical trial, expected to start in H1 2027.
The approach is interesting because MGX-001 aims to insert a functional Factor VIII gene into a specific location in the patient's DNA. The goal is to restore Factor VIII production through a potentially one-time treatment.
If successful, this could offer a new approach to treating Hemophilia A.
**2. ASH presentation – December 14**
Another upcoming catalyst is the American Society of Hematology (ASH) conference.
Metagenomi will present abstract #952 in an oral session on December 14.
The title is particularly interesting:
*In vivo targeted FVIII gene integration demonstrating pre-clinical safety, efficacy and durability supporting development of a one-time therapy for hemophilia A.*
Previous preclinical results have shown:
* Factor VIII levels reaching the normal physiological range.
* Durable expression for approximately 19 months in non-human primates.
* No detectable off-target editing in the reported assays.
Obviously, animal results don't guarantee success in humans, but these findings are encouraging.
**3. Financial position**
One thing I also like is the company's cash position. Metagenomi reported approximately $101.7 million in cash and marketable securities at the end of Q3 2026, with funding expected to last into 2028.
That should provide some breathing room as the company moves towards clinical testing.
**Why I'm watching MGX**
The biggest catalyst will ultimately be human clinical data in 2027. That's where we will find out whether the promising preclinical results translate into actual patients.
Of course, this is still a high-risk investment. Clinical trials can fail, gene editing has its challenges, and further dilution is always possible.
The combination of FDA clearance, promising preclinical data, a relatively strong cash position and upcoming clinical milestones makes this an interesting speculative biotech play.
But hey, this is just my first DD, so i would love the opinion of the pennystock community as well.
What's everyone's take on MGX? Anyone else following this one ahead of the ASH presentation?
*Disclaimer: Not financial advice. Do your own research!!*
sentiment 0.992
She can invest through her bank or through a broker such as De Giro. Neo brokers such as trading 212 or others should also work, but de giro has pretty good transaction fees. Some neo brokers will give you free transactions though I don't trust their earnings model in those cases, must be selling a lot of data that can be used against us.
Regarding books, I think most investing knowledge generalizes anyway. There's not much investing knowledge that is specific to the EU or US if you want to Bogle with world ETFs.
Some ETFs I'm buying myself as an EU citizen are AVIAW Cardano IND global and EMIM ishares core emerging markets fund.
At the time I was also using https://www.indexfondsenvergelijken.nl/ a dutch website to pick ETFs. Seems it has since stopped, though with wayback machine you could still use it but with outdated data, to get an idea of available funds with low rates.
sentiment 0.758